ESElena Solopova

Elena Solopova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Elena Solopova has a total of 37 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fatal Iatrogenic Cerebral Amyloid‐Related Encephalitis in a woman treated with lecanemab for Alzheimer’s disease

    by Elena Solopova

    Background: We report the case of a 79‐year‐old woman with Alzheimer’s disease who enrolled in a clinical study of lecanemab. After the third, biweekly infusion she suffered a seizure followed by aphasia and progressive encephalopathy. Magnetic resonance imaging revealed multifocal cerebral edema and an increased burden of cerebral microhemorrhages compared to pre‐trial imaging. She was treated with an antiepileptic regimen and high‐dose intravenous corticosteroids but continued to worsen and died after five days.Methods: Post‐mortem paraformaldehyde‐fixed coronal brain slices were embedded in degassed agarose solution and scanned with human clinical MRI scanners at 3 and 7 Tesla field strength. Free‐floating sections were immunostained using validated primary and corresponding secondary antibodies and imaged using a confocal laser‐scanning microscope. For three‐dimensional lightsheet microscopy, tissue blocks were embedded in CLARITY acrylamide hydrogel, optically cleared and stained with fluorescent probes and antibodies.Results: Post‐mortem MRI confirmed extensive microhemorrhages in the temporal, parietal and occipital lobes. The autopsy confirmed the presence of two copies of APOE4, a gene associated with a higher risk of Alzheimer’s disease, and neuropathological features of moderate severity Alzheimer’s disease and severe cerebral amyloid angiopathy with perivascular lymphocytic infiltrates, reactive macrophages and fibrinoid degeneration of vessel walls. There were deposits of β‐amyloid in meningeal vessels and penetrating arterioles with numerous microaneurysms.Conclusion: We conclude that the patient likely died as a result of severe cerebral amyloid‐related meningoencephalitis.

  • Migraine May Represent an Independent Risk Factor for Retinal Stroke: A Population-Based Cohort Study

    by Jay B Lusk, Ailin Song, Shakthi Unnithan, Hussein R. Al-Khalidi, Adam de Havenon, Valérie Biousse, Matthew Schrag, Elena Solopova, Sven Poli, Nosayaba Osazuwa-Peters, et al.


  • Open Access

    Arteriolar degeneration and stiffness in cerebral amyloid angiopathy are linked to β-amyloid deposition and lysyl oxidase

    by Lissa Ventura-Antunes, Alex Nackenoff, Wilber Romero-Fernandez, Allison M Bosworth, Alex Prusky, Emmeline Wang, Cristian Carvajal-Tapia, Alena Shostak, Hannah Harmsen, Bret Mobley, et al.

    Cerebral amyloid angiopathy (CAA) is a vasculopathy characterized by vascular β-amyloid (Aβ) deposition on cerebral blood vessels. CAA is closely linked to Alzheimer’s disease (AD) and intracerebral hemorrhage. CAA is associated with the loss of autoregulation in the brain, vascular rupture, and cognitive decline. To assess morphological and molecular changes associated with the degeneration of penetrating arterioles in CAA, we analyzed post-mortem human brain tissue from 26 patients with mild, moderate, and severe CAA end neurological controls. The tissue was optically cleared for three-dimensional light sheet microscopy, and morphological features were quantified using surface volume rendering. We stained Aβ, vascular smooth muscle (VSM), lysyl oxidase (LOX), and vascular markers to visualize the relationship between degenerative morphological features, including vascular dilation, dolichoectasia (variability in lumenal diameter) and tortuosity, and the volumes of VSM, Aβ, and LOX in arterioles. Atomic force microscopy (AFM) was used to assess arteriolar wall stiffness, and we identified a pattern of morphological features associated with degenerating arterioles in the cortex. The volume of VSM associated with the arteriole was reduced by around 80% in arterioles with severe CAA and around 60% in cases with mild/moderate CAA. This loss of VSM correlated with increased arteriolar diameter and variability of diameter, suggesting VSM loss contributes to arteriolar laxity. These vascular morphological features correlated strongly with Aβ deposits. At sites of microhemorrhage, Aβ was consistently present, although the morphology of the deposits changed from the typical organized ring shape to sharply contoured shards with marked dilation of the vessel. AFM showed that arteriolar walls with CAA were more than 400% stiffer than those without CAA. Finally, we characterized the association of vascular degeneration with LOX, finding strong associations with VSM loss and vascular degeneration. These results show an association between vascular Aβ deposition, microvascular degeneration, and increased vascular stiffness, likely due to the combined effects of replacement of VSM by β-amyloid, cross-linking of extracellular matrices (ECM) by LOX, and possibly fibrosis. This advanced microscopic imaging study clarifies the association between Aβ deposition and vascular fragility. Restoration of physiologic ECM properties in penetrating arteries may yield a novel therapeutic strategy for CAA.


  • Top Cited Papers
    Open Access

    Fatal iatrogenic cerebral β-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer’s disease

    by Elena Solopova, Wilber Romero-Fernandez, Hannah Harmsen, Lissa Ventura-Antunes, Emmeline Wang, Alena Shostak, Jose Maldonado, Manus J. Donahue, Daniel Schultz, Thomas M. Coyne, et al.

    We report the case of a 79-year-old woman with Alzheimer’s disease who participated in a Phase III randomized controlled trial called CLARITY-AD testing the experimental drug lecanemab. She was randomized to the placebo group and subsequently enrolled in an open-label extension which guaranteed she received the active drug. After the third biweekly infusion, she suffered a seizure characterized by speech arrest and a generalized convulsion. Magnetic resonance imaging revealed she had multifocal swelling and a marked increase in the number of cerebral microhemorrhages. She was treated with an antiepileptic regimen and high-dose intravenous corticosteroids but continued to worsen and died after 5 days. Post-mortem MRI confirmed extensive microhemorrhages in the temporal, parietal and occipital lobes. The autopsy confirmed the presence of two copies of APOE4, a gene associated with a higher risk of Alzheimer’s disease, and neuropathological features of moderate severity Alzheimer’s disease and severe cerebral amyloid angiopathy with perivascular lymphocytic infiltrates, reactive macrophages and fibrinoid degeneration of vessel walls. There were deposits of β-amyloid in meningeal vessels and penetrating arterioles with numerous microaneurysms. We conclude that the patient likely died as a result of severe cerebral amyloid-related inflammation.


  • Open Access

    Altered ubiquitination of phospholipase D3 contributes to lysosome dysfunction in Alzheimer’s Disease

    by Wilber Romero Fernandez, Lissa Ventura Antunes, Ketaki A. Katdare, Kylie M. Balotin, Alex Prusky, Elena Solopova, Alena Shostak, Emmeline Wang, Ethan S Lippmann, Matthew Schrag

    Background: Proteinopathy is a common feature of multiple neurodegenerative diseases. Recent studies have demonstrated lysosomal dysfunction is closely linked to neurodegenerative proteinopathies. In the context of Alzheimer’s disease (AD), the lysosomal protein phospholipase D3 (PLD3) has been identified as a potential molecular player, but PLD3’s distinct role in lysosome function is not completely understood.Method: We used immunohistochemistry, western blot, and proximity ligation assays to determine PLD3’s localization, expression level, post‐translational modification and protein‐protein interaction profile. Experiments were performed using iPSC‐neuron cultures and human brain tissue obtained from patients with AD and neurological controls through the Vanderbilt Brain and Biospecimen Bank.Result: PLD3 is neuronal widely distributed throughout brain regions relevant to memory and cognition and PLD3 levels were significantly lower in AD brains compared to the controls. We discovered that PLD3 ubiquitination was significantly increased in AD brains relative to the controls, providing a possible explanation for the PLD3 reduction and localization into hallmark pathological structures of the AD brain. Furthermore, PLD3‐ubiquitin complexes were enriched in parenchymal β‐amyloid deposits and intraneuronal tau pathologies, both neuropil threads and neurofibrillary tangles.We provide the first experimental evidence for the physical interaction between PLD3 and Cathepsin D (CTD), both in human brain tissue and iPSC neurons. The interaction between PLD3/CTD was promoted by exposure of iPSC‐neurons to human Aβ seeds isolated from post‐mortem brain, suggesting this protein‐protein interaction is relevant to Aβ pathology. We found this heterodimer was dramatically reduced in AD brain, especially in dystrophic neurites. The loss of this interaction in dystrophic neurites is notable because even though PLD3 levels are reduced in the AD brain, both PLD3 and CTD are present in abundance around β‐amyloid plaques. The loss of PLD3/CTD interaction observed in AD brain is only partly explained by reduced expression of both proteins, so it is likely that an alteration in lysosome function is impacting this protein‐protein interaction.Conclusion: This study revealed an important role for both PLD3 ubiquitination and as an interaction partner for CTD within lysosomes. It will be interesting to further dissect the molecular mechanisms underlying the PLD3/CTD interaction.